Clinical trial NCT00585663 - References

Coronary Artery Disease — Accuracy of Radiolabeled Fatty Acid Analog, BMIPP, in the Late Detection of Decreased Blood Flow to the Heart

Citation(s)

•   Dilsizian V, Bateman TM, Bergmann SR, Des Prez R, Magram MY, Goodbody AE, Babich JW, Udelson JE
  Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation. 2005 Oct 4;112(14):2169-74. Epub 2005 Sep 26.
•   Knapp FF Jr, Kropp J
  Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med. 1995 Apr;22(4):361-81. Review.
•   Morimoto K, Tomoda H, Yoshitake M, Aoki N, Handa S, Suzuki Y
  Prediction of coronary artery lesions in unstable angina by iodine 123 beta-methyl iodophenyl pentadecanoic acid (BMIPP), a fatty acid analogue, single photon emission computed tomography at rest. Angiology. 1999 Aug;50(8):639-48.

Phase 2 Study of the Safety and Efficacy of ß-Methyl-p-[123I]-Iodophenyl-Pentadecanoic Acid for Identification of Ischemic Myocardium Using SPECT in Adults With Symptoms Consistent With Acute Coronary Syndrome

Details for clinical trial NCT00585663